ACHE and early-onset autosomal dominant Alzheimer disease: Due to the pivotal role in cholinergic transmission, AChE is an important target for synthetic drugs used for symptomatic treatment of Alzheimer’s disease [6,7], for antidotes used to counteract organophosphorus compounds (i.e., pesticides and nerve agents) [8], and for insecticides used to control vector borne diseases [9].